AUREOMYCIN IN URINARY TRACT INFECTIONS—PRELIMINARY CLINICAL REPORT
Authors: S W RUBIN, A E GOLDSTEIN
Journal: Annals of Internal Medicine (1950)

Article1 April 1950AUREOMYCIN IN URINARY TRACT INFECTIONS—PRELIMINARY CLINICAL REPORTSEYMOUR W. RUBIN, M.D., ALBERT E. GOLDSTEIN, M.D.SEYMOUR W. RUBIN, M.D.Search for more papers by this author, ALBERT E. GOLDSTEIN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-32-4-661 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptUrinary tract infection is second only to upper respiratory infection in incidence. Moreover, the causative organisms are easily identified. The treatment of such infections, however, often taxes the ability of the ablest clinician.Of the many pathogenic bacteria that have at one time or another been isolated from the urine, only about a half dozen cause us repeated and frequent concern. Urinary organisms are immediately separated into gram negative bacilli or gram positive cocci. Among the gram negative bacilli we invariably find, either singly or in combination,1. Escherichia colt2. Aerobacter aerogenes3. Pseudomonas aeruginosa (B. pyocyaneus)4.Proteus...Bibliography1. Conference on aureomycin: Ann. N. Y. Acad. Sc. 51: 175-342, 1948. CrossrefGoogle Scholar2. BryerSchoenbachChandlerBlissLong MSEBCAEAPH: Aureomycin, J. A. M. A. 138: 117-119, 1948. CrossrefMedlineGoogle Scholar3. CollinsPaineWellsFinland HSTFEBM: Aureomycin—a new antibiotic: evaluation of its effects in typhoid fever, severe salmonella infections and in a case of colon bacillus bacteremia, Ann. Int. Med. 29: 1077-1092, 1948. LinkGoogle Scholar4. Heilman FR: Aureomycin in the treatment of experimental relapsing fever and leptospirosis icterohemorrhagica (Weil's disease), Proc. Staff Meet., Mayo Clin. 23: 569-573, 1948. MedlineGoogle Scholar5. O'LearyKierlandHerrell PARAWE: Oral administration of aureomycin (Duomycin) and its effect on Treponema pallidum in man, Proc. Staff Meet., Mayo Clin. 23: 574-578, 1948. MedlineGoogle Scholar6. PaineCollinsFinland TFHSM: Bacteriologic studies on aureomycin, J. Bact. 56: 489-497, 1948. CrossrefMedlineGoogle Scholar7. RossSchoenbachBurkeBryerRiceWashington SEBEBMSECJA: Aureomycin therapy of Rocky Mountain spotted fever, J. A. M. A. 138: 1213-1216, 1948. CrossrefMedlineGoogle Scholar8. SchoenbachBryer EBMS: Treatment of primary atypical non-bacterial pneumonia with aureomycin, J. A. M. A. 139: 275-280, 1949. CrossrefMedlineGoogle Scholar9. SpinkBraudeCastanedaGoytia WWASMRRS: Aureomycin therapy in human brucellosis due to Brucella melitensis , J. A. M. A. 138: 1145-1148, 1948. CrossrefMedlineGoogle Scholar10. WrightSandersLoganPrigotHill LTMMAALM: Aureomycin: a new antibiotic with virucidal properties, J. A. M. A. 138: 408-412, 1948. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Baltimore, Maryland*Received for publication June 21, 1949.From the Department of Urology, Sinai Hospital. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAntibiotikaAntibiotikaAureomycin in Urinary Tract Infections 1 April 1950Volume 32, Issue 4Page: 661-672KeywordsBacteriaBacterial pathogensPseudomonas aeruginosaTaxesUpper respiratory tract infectionsUrinary tract infectionsUrineUrology ePublished: 1 December 2008 Issue Published: 1 April 1950 PDF downloadLoading ...